Wolfgang Miesbach: Translating Gene Therapy into Haemophilia Care at EHA 2026
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Honoured to be speaking at EHA 2026 this Friday, 12 June in the ‘Gene engineering and therapy’ session.
In ‘Translating Genetic Innovation into Haemophilia Care’ (P141-2), I’ll explore how three decades of gene therapy development are reshaping not just treatment, but how care itself is organised — from the structure of treatment centres to the way we follow patients across their lifetimes.
Haemophilia has long been a proving ground for genetic medicine, and the lessons here ripple out to many other conditions.
I’ll also reflect on a sobering reality: some gene therapies are being pulled from the market not because they failed patients, but because the business model did.
The future of genetic medicine may depend less on what we can cure than on what our systems are willing to pay for.”
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI